glp-1 approved for pcos Rising use of medications among women with Liraglutide and polycystic ovary syndrome:

Early trials of next-generation agents, oral small-molecule glucagon-like peptide 1 (GLP-1) agonists such as orforglipron and triple agonists such as retatrutide, show even greater or comparable efficacy and new routes of administration [7,8]

When the cause is telogen effluvium, the shedding is usually temporary

Diabetologia 53(suppl 1):S341 Adame J, Cohen PR (1996) Eosinophilic panniculitis: diagnostic considerations and evaluation

doi: 10.1016/S2213-8587(25)00226-8 10 WaddenTABaileyTSBillingsLKDaviesMFriasJPKorolevaAet al

How quickly should I expect weight loss

Understanding Semaglutide's Timeline for Weight Loss Results Semaglutide begins affecting appetite within the first few doses, typically producing appetite reduction and early weight changes by week 2 to 3